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Introduction 
In the last decade, a large number of studies has investigated the accuracy of imaging 
tests that assess the optic nerve head (ONH) and retinal nerve fiber layer (RNFL) 
thickness for diagnosing glaucoma.1-9 Despite the amount of information available, a 
recent Cochrane review found suboptimal study design in nearly all diagnostic accuracy 
studies, since they adopted a case-control design which is known to overestimate 
accuracy.10 
The GATE study is a large, multicenter, prospective test accuracy study that investigated 
the performance of automated classifications of three common imaging technologies for 
diagnosing manifest glaucoma, the Heidelberg Retina Tomography (Heidelberg 
Engineering, Heidelberg, Germany), scanning laser polarimetry (GDx-ECC, Carl Zeiss 
Meditec, Dublin, CA) and Spectralis optical coherence tomography (OCT, Heidelberg 
Engineering, Heidelberg, Germany). The performance of a triage test including imaging, 
intraocular pressure (IOP) and visual acuity was evaluated.  In triage the new test is used 
before the existing testing pathway (e.g., clinical examination and visual field testing for 
glaucoma). The target population was selected in a well-defined step of the clinical 
pathway: patients referred by optometrists to hospital eye services in UK after prior testing 
identified increased risk for, or suspicion of, glaucoma.11,12 Although the use of an imaging 
technology as part of a triage test was found to be efficient,  the GATE study described 
suboptimal performance of OCT when the standard automated classification of the global 
RNFL thickness was used, which included the categories ‘within normal limits’, ‘borderline’ 
or ‘outside normal limits’. 
OCT is the most widespread imaging technology.  In this in-depth analysis of GATE study 
OCT data, we wished to explore further objectives: what is the performance of OCT at a 
3 
 
3 
 
pre-defined high sensitivity level (needed for a triage setting, such as in the GATE study) 
or at high specificity level (needed for a screening setting, for which GATE would only 
provide indirect evidence), and what RNFL thickness cut-offs could be used for triage or 
screening, respectively?  Other questions included: can glaucoma diagnosis be improved 
using additional information relating to the subject’s between- and within-eye variation and 
other data available such as OCT scan quality, intraocular pressure (IOP), patient’s age 
and refractive error?  
 
Materials and Methods  
Study design and participants have been described before.11 In brief, in the GATE study 
we conducted a pragmatic multicentre within-patient comparative evaluation of the 
diagnostic accuracy of automated imaging techniques for diagnosis of glaucoma.11  
Institutional Review Board (IRB)/Ethics Committee approval was obtained.  We recruited 
966 participants prospectively and consecutively among 2088 participants referred to five 
UK hospital eye services from community optometrists and invited to attend the study. An 
ophthalmologist with glaucoma expertise performed a clinical assessment which formed 
the reference standard.  Clinical examination included Goldmann applanation tonometry, 
gonioscopy, biomicroscopic examination of the optic disc (pupils dilated unless 
contraindicated) and evaluation of the visual field test with Humphrey SITA 24-2.  
Glaucoma experts participating in the study met before starting the study and used a pre-
agreed definition of glaucoma.11,12  Manifest glaucoma was classified with visual field 
assessment as mild, moderate or severe using mean deviation cut-offs of -6 dB and -12 
dB. Imaging test results were not available to the ophthalmologist and the imaging 
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technician was also masked to glaucoma status assessment.  All participants in the GATE 
study who underwent OCT were included in this study. 
The primary analysis included data using from both eyes.  A participant was defined as 
having glaucoma if the manifest glaucoma was diagnosed in one or both eyes, i.e. 
considering glaucoma-suspects as case-negatives.  We conducted a secondary analysis 
including suspect and manifest glaucoma cases as positive diagnosis.  We used receiver 
operator characteristics (ROC) curve analysis to assess the performance of RNFL 
thickness for diagnosing manifest glaucoma. 13 Diagnostic factors were analyzed and then 
sequentially combined as follows. Based on a recent systematic review and primary 
research,10,14  we selected RNFL average and inferior quadrant thickness as OCT 
parameters of interest as they have previously been shown to have the highest diagnostic 
accuracy. We also extracted the absolute value of the difference between the inferior-
temporal and the superior-temporal sector as a measure of within-eye difference, since 
this topographic comparison resembles one of the perimetric criteria for diagnosing 
glaucoma (i.e. Glaucoma Hemifield Test).15 The absolute value of the interocular 
difference in RNFL thickness was used as a measure of between-eye variation.16  
We compared the medians of patient-level relevant variables in manifest glaucoma versus 
other groups using a nonparametric k-sample test on the equality of medians. We used 
logistic regression-based ROC analysis to build a set of models adding one parameter at a 
time with the following prespecified sequence: RNFL thickness in the eye with the lower 
value, either average or inferior quadrant; absolute interocular difference, average or 
inferior quadrant; absolute difference between inferior and superior temporal sectors; and 
the average quality of the two scans in the subject’s eyes. Then, we considered the 
following variables in the model as they can be obtained at any optometrists’ practice: 
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intraocular pressure (IOP) as the higher measure in either eye; refractive error as spherical 
equivalent, higher absolute value of the two eyes; and age. Sensitivity at 95% specificity 
and specificity at 95% sensitivity were calculated from ROC curves based on percentile 
value calculations according to Pepe et al.16 using 1000 bootstrap samples. 
In a second set of exploratory sensitivity analyses, we considered an identical set of 
measures with data measured at the eye level, i.e. using two records per patient, adjusting 
for within-subject correlation in ROC analyses using logistic regression models with a 
clustered sandwich estimator.  
The effect measure to select the best model was initially the AUC. We also obtained the 
specificity at 0.95 sensitivity and a priori considered that a specificity of at least 0.50 was 
acceptable for a SpPin test (specificity, positive result good for ruling in disease), reducing 
the burden of referrals with minimal loss of glaucoma cases. Vice versa, a SnNout test 
(sensitivity, negative result good for ruling out disease) was deemed acceptable at a 
minimum 0.95 sensitivity and 0.50 specificity.17  For univariate analyses of RNFL 
thickness, we recorded the cut-off at which such high sensitivity and specificity values 
were obtained. 
We computed Diagnostic Odds Ratios (DORs) at 0.95 specificity or 0.95 sensitivity for 
models including a single variable, either average or inferior RNFL thickness. 
No imputation of missing data was applied since data were complete at over 95%. 
Participants were excluded from analyses only if the scan quality score was 15 or less in 
either eye, as stated in the protocol, since the likelihood of a correct glaucoma 
classification is reduced in this case 
All calculations were made using Stata 14.1 (StataCorp, College Station, TX). 
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Results 
A complete description of the patients’ enrollment and flow in the GATE study has been 
previously published.11 A flow diagram of participants included in this study is shown in 
figure 1. Out of 2088 subjects who were invited to attend, 966 participants (48%) 
consented into GATE study, of whom 11 were not referred for glaucoma and 1 withdrew, 
leaving 955 eligible patients. Of these, 56 were excluded (see Figure 1). Mean age was 62 
years (standard deviation: 14 years) and 49% of participants were male. After clinician 
evaluation, manifest glaucoma was found in 55 participants in the right eye only, in 43 
participants in the left eye only, while in 55 participants it was diagnosed in both eyes, 
totaling 153 participants with glaucoma in at least one eye (17%);  235 (26.1%) 
participants were suspect for glaucoma in at least one eye  
Figure 2 shows the distribution of all variables in glaucoma and non-glaucoma cases as 
boxplots. There were significant differences  (p≤0.001) between non-glaucoma and 
glaucoma participants in median values of all RNFL thickness parameters and other 
variables, as defined in the Methods: average RNFL thickness (89 versus 69 micron) or 
inferior RNFL thickness (111 versus 74 micron), the interocular difference of the average 
RNFL thickness (1.5 versus 5 micron) or inferior quadrant RNFL thickness (4 versus 11.5 
micron), the largest difference in RNFL thickness between superior-temporal and inferior-
temporal sectors (10 versus 17.5 micron), scan quality (28.5 versus 25.8), spherical 
equivalent refractive error (0.75 D versus 2.38 D) and age (62 versus 71 years), while 
median IOP did not differ (21.5 vs 22 mmHg, p=0.740). Despite these significant 
differences a substantial overlap is seen for all parameters between glaucoma and non-
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glaucoma participants (Figure 2), and particularly the upper quartile of glaucoma 
participants generally overlapped with the middle quartiles of non-glaucoma participants.  
 
ROC curve analysis 
Figure 3 presents ROC curves of all variables of interest in groups of three variables to 
improve clarity. The ROC curve of the average and inferior RNFL thickness overlapped, 
though inferior thickness seemed to be better than average thickness at high specificity 
levels in the lower-left corner of the ROC plane. With reference to the AUC of the average 
thickness (0.83), that of the inferior was similar (0.83, p=0.668), while all others were 
significantly lower than average RNFL thickness (p≤0.001): interocular difference in 
average (0.74) or in inferior quadrant thickness (0.72), difference of superior to inferior 
temporal sectors (0.71), scan quality (0.68), age (0.67), spherical equivalent (0.61), IOP 
(0.55). 
Table 1 shows the performance of a series of models in which variables are added one at 
a time based on the sequence explained in the Methods. AUCs were between 0.83 and 
0.88. Sensitivity at 0.95 specificity was between 0.36 and 0.55 for all models, the highest 
values were reached by models including the inferior quadrant rather than the average 
RNFL thickness. Specificity at 0.95 sensitivity was also found to range between about 0.36 
and 0.58.  
Figure 3 shows that, at high specificity, the better performance of the inferior quadrant 
compared to the average was due to the irregular shape of the ROC curve for the inferior 
quadrant compared to the average at high specificity in the left and lower corner of the 
ROC space. A sensitivity analysis using a parametric (binormal) ROC model gave almost 
overlapping curves and sensitivity estimates of 0.45 and 0.43 for average and inferior 
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parameters, respectively. An alternative analysis at 0.90 specificity found that sensitivity 
was 0.57 and 0.56, respectively. 
For the average, DORs were 10.7 and 11.6, whereas for inferior thickness they were 23.2 
and 12.1, respectively, which can be considered a modest accuracy performance.  
Threshold analysis and secondary analyses 
ROC data tabulation found that a high specificity of 0.95 was found at a threshold of ≤62 
micron for the average (sensitivity 0.38) and ≤77 micron for the inferior quadrant 
(sensitivity 0.55) RNFL thickness. The thresholds for reaching a high sensitivity of 0.95 
were ≤92 micron and ≤117 micron, resulting in a specificity of 0.36 and 0.39 for the 
average and inferior RNFL thickness, respectively (Table 1).  
Using the highly sensitive cut-off in a cohort of 1000 screened subjects containing 170 with 
glaucoma, triage with OCT would result in the referral of 692 participants with average 
RNFL thickness ≤92 micron or 667 participants with inferior quadrant thickness ≤117 
micron, in order to detect 161 participants with glaucoma in at least one eye, while missing 
9 patients. Data on the severity of glaucoma suggested that 6 missed participants would 
have mild glaucoma (out of 93 with mild glaucoma in the hypothetical cohort, 6% missed) 
and 3 would have moderate or severe glaucoma (out of 77 with moderate or severe 
glaucoma, 4% missed).   
Pooling manifest glaucoma (n. 153) with suspect glaucoma (n. 233) in either eye to form 
the target condition, for average and inferior quadrant RNFL thickness the accuracy 
figures would be, respectively: AUC 0.73 (95%CI: 0.70 – 0.77) and 0.72 (95%CI: 0.68 – 
0.75); sensitivity at 0.95 specificity 0.28 (95%CI: 0.19 – 0.38) and 0.27 (95%CI: 0.20 – 
0.32); specificity at 0.95 sensitivity 0.13 (95%CI: 0.08 – 0.22) and 0.10 (95%CI: 0.06 – 
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0.19). Using the same target condition, at 0.90 specificity, sensitivity would be 0.44 (95%CI 
0.36 – 0.50) and 0.37 (95%CI 0.28 – 0.43) for average and inferior quadrant RNFL 
thickness, respectively.  
Figure 4 presents the positivity fraction for each diagnosis category using the highly 
sensitive cut-off of 117 micron or less for the inferior sector, where the detection rate of 
manifest glaucoma was 95% by design. Estimates are displayed separately for right and 
left eyes, which show consistent patterns. The positivity fraction for OHT was 63-65% and 
was similar to that of eyes with no glaucoma-related findings, whereas glaucoma-suspects 
had a higher referral rate, particularly for disc/VF suspects (Figure 4). 
In sensitivity analyses on statistical modelling, models using an identical set of measures 
with data measured at the eye level (i.e. using one record per eye, adjusting for within-
subject correlation in ROC analyses)  either had poor convergence or did not change 
accuracy estimates (data available upon request). 
 
Discussion 
This in depth analysis of GATE data aimed at measuring the accuracy of OCT parameters 
at high levels of either sensitivity or specificity that would be relevant for a triage or 
screening setting, respectively, and to explore the potential for improvement in accuracy 
by adding parameters that are easily available to primary eye care professionals, such as 
within-subject symmetry data, OCT scan quality, age, refractive error and IOP.   We 
selected the global and inferior RNFL based on a recent systematic review that found 
these parameters to have the highest diagnostic accuracy.  We found the improvement in 
diagnostic performance obtained in this way is modest.  OCT accuracy is likely better 
using inferior sector RNFL thickness at high sensitivity, reaching about 0.50 specificity.   
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The addition of data on between-eye and within-eye asymmetry, as well as age, refractive 
error and IOP did not improve substantially the diagnostic performance of the simple, 
easy-to-use automated classification that we used in GATE. 
Since a large Cochrane review has shown that almost all studies on ONH and RNFL 
imaging tests for diagnosing glaucoma were case-control studies,10 only recently have 
large diagnostic studies been conducted that measures the accuracy of OCT in a cohort of 
prospectively enrolled subjects according to a single and well-defined question made in a 
screening14 or primary care referral11,12 setting.  Different study designs and settings can 
lead to measuring different test performances. Particularly, it is well known that case-
control studies overestimate accuracy.18,19 
In a case-detection context, where glaucoma prevalence was about 5%, Dabasia et al14 
found that iVue OCT (Optovue, Fremont, CA) sensitivity at 90% specificity for detection of 
glaucoma suspect/POAG combined was 0.57 (0.44-0.70) and for POAG, it was 0.83 (0.68-
0.98) for best-performing OCT parameter, i.e. inferior quadrant RNFL thickness. 
Combining different tests was found to be useful to increase post-test probability. This 
study cannot be compared with ours because of the community-based triage setting and 
the adoption of a different OCT device. 
 The GATE study11 found OCT sensitivity was 0.77 and specificity was 0.79 for diagnosing 
manifest glaucoma using the Spectralis RNFL classification of outside normal limits. 
Combination of two different imaging tests did not improve substantially the diagnostic 
accuracy. The DOR was 12.2 for the automated classification in the primary GATE 
analysis, which was achieved about at the diagonal of the ROC curve, where sensitivity 
equals specificity. This DOR value is similar to those found for average and inferior RNFL 
thickness in our analyses, which is consistent with the fact that we sought to obtain 
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accuracy estimates at very high sensitivity or specificity. Though such DOR values are 
usually regarded as modest accuracy, these secondary analyses of GATE data aimed to 
define RNFL thickness threshold values at the boundary of the ROC curve that may be 
useful in clinical settings (e.g., triage or case detection) to prioritize either case detection or 
the reduction of referrals when accuracy is suboptimal.   
The strengths of the GATE study are its prospective design and multicenter data collection 
on a large number of participants for whom a well-defined question was made: whether 
imaging tests could be used as triage test on referrals by optometrists to hospital eye 
services. However, there are some potential limitations.  The analyses conducted in this 
secondary publication were only partly pre-specified, thus exploratory in nature.  Two of 
the participating units recruited a relatively small number of potential participants thus the 
recruits were not necessarily consecutive.  Although consensus among clinicians at 
different sites was sought trhough structured discussion and agreement, some assessor 
differences may have remained.  In addition, the population included in GATE would not 
be representative of the general population and thus the potential applicability of this study 
for informing the value of OCT for screening needs to be interpreted with caution. In fact, 
GATE provides accuracy estimates that can be generalized to triage settings with a similar 
profile of referrals, whereas it can offer at best indirect evidence for researchers planning 
population-based screening or case-detection studies.   The reliability of our estimates of 
sensitivity may be limited by the small absolute number of false positives, but was still 
sufficient to make values above 0.50-0.60 implausible when the specificity was fixed at 
0.95. Moreover, our estimates of cut-off values to achieve desired accuracy levels should 
be confirmed in further research in order to be generalizable to other settings.  However it 
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is uncertain whether the results of this study may be generalizable to other OCT 
instruments.   
Diagnosing glaucoma during the very early stage of disease is challenging. It is possible 
OCT may correctly detect pre-perimetric disease and thus a positive test may be wrongly 
considered to be a false positive. Ideally a longitudinal follow-up would provide the best 
possible reference standard.     
The analyses presented in this secondary publication provide further information on 
Spectralis OCT accuracy at high sensitivity or high specificity, as well as retinal thickness 
cut-offs to achieve them.  When using OCT for triaging glaucoma, the overall RNFL, the 
inferior RNFL thickness data and the addition of between-eye and within-eye asymmetry 
data, as well as age, refractive error and IOP did not improve substantially the diagnostic 
performance of the simple, easy to use Spectralis automated classification as used in 
GATE. 
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Figure Legends: 
 
Figure 1. Participants’ flow. 
 
Figure 2. Boxplots of OCT parameters, spherical equivalent, IOP and age for non-
glaucoma (left in each square) and glaucoma (right in each square) cases. Average and 
inferior RNFL thickness is recorded as the lower value in either eye of each patient, 
interocular difference as the absolute value, superior-temporal to inferior-temporal 
difference as the absolute value of the larger difference in either eye of each patient, scan 
quality as the mean value of the patient’s eyes, spherical equivalent as the more positive 
measure of the patient’s eyes, IOP as the higher measure of the patient’s eyes. 
 
Figure 3. ROC curves of all parameters for detecting manifest glaucoma.  
 
 
